PVIVX
Price
$60.08
Change
+$0.17 (+0.28%)
Updated
Jul 31 closing price
Net Assets
173.2M
VSCIX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

PVIVX vs VSCIX

PVIVX vs VSCIX Comparison Chart in %
View a ticker or compare two or three
VS
PVIVX vs. VSCIX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PVIVX is a Hold and VSCIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 189B vs. PVIVX (173M). VSCIX pays higher dividends than PVIVX: VSCIX (1.23) vs PVIVX (0.00). PVIVX was incepted earlier than VSCIX: PVIVX (19 years) vs VSCIX (29 years). PVIVX (1.26) is less costly to investors than VSCIX (0.03). PVIVX is a more actively managed with annual turnover of: 86.64 vs. VSCIX (17.00). PVIVX has a lower initial minimum investment than VSCIX: PVIVX (2500) vs VSCIX (5000000). PVIVX annual gain was more profitable for investors over the last year : 24.34 vs. VSCIX (22.58). VSCIX return over 5 years is better than : 35.13 vs. PVIVX (14.13).
PVIVXVSCIXPVIVX / VSCIX
Total Expense Ratio1.260.034,200%
Annual Report Gross Expense Ratio1.260.034,200%
Fund Existence19 years29 years-
Gain YTD34.01714.591233%
Front LoadN/AN/A-
Min. Initial Investment250050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets173M189B0%
Annual Yield % from dividends0.001.23-
Returns for 1 year24.3422.58108%
Returns for 3 years17.9743.4441%
Returns for 5 years14.1335.1340%
Returns for 10 years129.05156.0783%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSPKX20.050.12
+0.60%
Goldman Sachs US Eq Div and Prem Instl
GSIQX23.62N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R
HSIIX29.59-0.08
-0.27%
Carillon Eagle Small Cap Growth I
CCWSX21.56-0.16
-0.74%
Baird Chautauqua International Gr Inv
RYCFX49.56-1.15
-2.27%
Rydex Biotechnology C